NO944120L - 1-[2H-1-benzopyran-2-on-8-ylÅ-piperazinderivater - Google Patents

1-[2H-1-benzopyran-2-on-8-ylÅ-piperazinderivater

Info

Publication number
NO944120L
NO944120L NO944120A NO944120A NO944120L NO 944120 L NO944120 L NO 944120L NO 944120 A NO944120 A NO 944120A NO 944120 A NO944120 A NO 944120A NO 944120 L NO944120 L NO 944120L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
benzopyran
trifluoromethyl
halogen
Prior art date
Application number
NO944120A
Other languages
English (en)
Norwegian (no)
Other versions
NO944120D0 (no
Inventor
Bartholomeus Johannes Va Steen
Johannes Antonius Maria Heyden
Jacques Schipper
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of NO944120D0 publication Critical patent/NO944120D0/no
Publication of NO944120L publication Critical patent/NO944120L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO944120A 1993-11-02 1994-10-28 1-[2H-1-benzopyran-2-on-8-ylÅ-piperazinderivater NO944120L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203058 1993-11-02

Publications (2)

Publication Number Publication Date
NO944120D0 NO944120D0 (no) 1994-10-28
NO944120L true NO944120L (no) 1995-05-03

Family

ID=8214152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944120A NO944120L (no) 1993-11-02 1994-10-28 1-[2H-1-benzopyran-2-on-8-ylÅ-piperazinderivater

Country Status (15)

Country Link
EP (1) EP0650964A1 (fr)
JP (1) JPH07188207A (fr)
KR (1) KR950014103A (fr)
CN (1) CN1105360A (fr)
AU (1) AU675880B2 (fr)
CA (1) CA2134630A1 (fr)
CZ (1) CZ265994A3 (fr)
FI (1) FI945086A7 (fr)
HU (1) HUT72320A (fr)
IL (1) IL111461A (fr)
NO (1) NO944120L (fr)
NZ (1) NZ264810A (fr)
RU (1) RU94039284A (fr)
SK (1) SK130694A3 (fr)
ZA (1) ZA948520B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3989554B2 (ja) 1996-03-29 2007-10-10 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ ピペラジンおよびピペリジン化合物
HUP9601331A3 (en) * 1996-05-17 2000-06-28 Egyt Gyogyszervegyeszeti Gyar Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
ATE253058T1 (de) 1997-09-02 2003-11-15 Duphar Int Res Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten
EP0900792B1 (fr) * 1997-09-02 2003-10-29 Duphar International Research B.V Dérivés de pipéridine et de pipérazine comme agonistes du récepteur 5-HT1
TW530054B (en) 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
ES2323451T7 (es) 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
CN1328273C (zh) * 2003-12-26 2007-07-25 中国科学院理化技术研究所 以环烷烃酮类连接的香豆素类染料及其合成方法和用途
SE0400759D0 (sv) * 2004-03-23 2004-03-23 Astrazeneca Ab Novel amination process
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
US20050215551A1 (en) 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
CA2570096A1 (fr) * 2004-07-15 2006-01-19 Solvay Pharmaceuticals B.V. Preparation a liberation prolongee de 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-one
AR055041A1 (es) 2005-03-23 2007-08-01 Merck Frosst Canada Ltd Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas.
KR100698550B1 (ko) * 2005-05-16 2007-03-22 원종필 내화 및 단열 성능 향상을 위한 시멘트 모르타르 조성물
CN102267966B (zh) * 2011-08-01 2013-02-27 华中科技大学 取代的苯并吡喃酮类衍生物及其应用
CN108752300B (zh) * 2018-05-16 2022-03-25 中国科学院昆明植物研究所 苄烯叉苯肽类化合物及其药物组合物和其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92544A0 (en) * 1988-12-08 1990-08-31 Duphar Int Res Piperazine derivatives,their preparation and pharmaceutical compositions containing them
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
FI945086A0 (fi) 1994-10-28
NZ264810A (en) 1996-02-27
CZ265994A3 (en) 1995-05-17
FI945086L (fi) 1995-05-03
FI945086A7 (fi) 1995-05-03
RU94039284A (ru) 1996-08-10
AU7756294A (en) 1995-06-01
IL111461A0 (en) 1994-12-29
HUT72320A (en) 1996-04-29
IL111461A (en) 1998-06-15
SK130694A3 (en) 1995-07-11
NO944120D0 (no) 1994-10-28
EP0650964A1 (fr) 1995-05-03
JPH07188207A (ja) 1995-07-25
ZA948520B (en) 1995-06-26
HU9403110D0 (en) 1994-12-28
KR950014103A (ko) 1995-06-15
CN1105360A (zh) 1995-07-19
AU675880B2 (en) 1997-02-20
CA2134630A1 (fr) 1995-05-03

Similar Documents

Publication Publication Date Title
NO944120L (no) 1-[2H-1-benzopyran-2-on-8-ylÅ-piperazinderivater
DE69229834T2 (de) Piperazinderivate als 5-ht rezeptor antagonisten
AU4437896A (en) Piperidine derivatives having tachykinin antagonist activity
DE69033100T2 (de) Piperazin-Derivate
DE69529670T2 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
NO954453L (no) Nye pyridin-, pyrimidin- og benzenderivater som adreno-ceptorantagonister
DD206991A5 (de) Verfahren zur herstellung neuer piperazinone
NO941611L (no) Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser
DE60203481T2 (de) Piperidinderivate als neurokinin 1 antagonisten
DE2557341A1 (de) Basisch substituierte indolderivate und verfahren zu ihrer herstellung
ATE126227T1 (de) Verwendung von (omega-(4-(2-pyrimidinyl)-1- piperazinyl)-alkyl)1h-azolderivate für die herstellung von heilmitteln zur behandlung von störungen kognitiver funktionen.
ATE147071T1 (de) 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
GB2057439A (en) Quinazolinones
ATE155133T1 (de) Piperazinderivate als 5-ht antagonisten
NO962855D0 (no) Nye piperidin-derivater med PAF-antagonist-aktivitet
JP5349305B2 (ja) 脊髄性筋萎縮症のための２，４−ジアミノキナゾリン
DE59406126D1 (de) Aminochinolin-Derivate mit einer Wirksamkeit gegen Malariaerreger
MX2024011914A (es) Derivados de n-(pirrolidin-3-il o piperidin-4-il)acetamida
NO984861L (no) Piperidiner og pyrrolidiner
US3922266A (en) Aryl ketones and production thereof
NO891501L (no) Hetera-alifatiske karboksamider.
NO914056L (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
NO996290L (no) 3-benzylpiperidiner
ATE121383T1 (de) Polyhydroxycyclopentan derivate, ihre herstellung und ihre therapeutische verwendung.
GB1304069A (fr)